NASA / NA-Semax Amidate
The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. None of the compounds covered are approved for the uses described here by the U.S. FDA, Australia's Therapeutic Goods Administration (TGA), New Zealand's Medsafe, or the equivalent regulator in most other countries.
Most are sold for laboratory research only, a few are prescription-only drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful wherever you live. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.
Cross-checked against 50–100 independent sources per claim — the house standard. How this reference is checked
A stabilized N-acetylated, C-amidated analog of Semax (an ACTH 4-10 fragment) engineered for a longer half-life and better blood-brain-barrier penetration, used by subcutaneous injection or intranasal drops by people seeking focus, BDNF modulation and neuroprotection. The parent Semax has decades of Russian clinical use, but the acetylated-amidated analog itself has essentially no controlled human trials, so effects are extrapolated from the parent and from user reports. Popular and widely reported as well-tolerated in practice, but the evidence base for this specific molecule is minimal.
The full published spec sheet — dose units, timing, frequency, and cycle length — is included with membership.
The published dose for this compound, shown as reference. Included with membership.
Reference values as published in the research record — not a recommendation, instruction, or dose suggestion for any person. Not medical advice.
The live calculator — enter any vial size, diluent volume, and syringe size to see the draw computed — is included with membership.